The impact of concomitant medications on treatment outcomes in patients with cancer receiving immune checkpoint inhibitors
Concomitant medications are emerging as a modifiable prognostic factor for immune checkpoint inhibitor treatment outcomes. This Review by Stone et al. highlights the potential immunomodulatory interactions of commonly prescribed medications and supplements, a…
CAS
PubMed
Google Scholar